- Home
- NA vs AKTX Comparison
NA vs AKTX Comparison
Compare NA & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NA
- AKTX
- Stock Information
- Founded
- NA 2019
- AKTX N/A
- Country
- NA China
- AKTX United States
- Employees
- NA N/A
- AKTX N/A
- Industry
- NA Semiconductors
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- NA Technology
- AKTX Health Care
- Exchange
- NA Nasdaq
- AKTX Nasdaq
- Market Cap
- NA 32.3M
- AKTX 29.5M
- IPO Year
- NA 2022
- AKTX N/A
- Fundamental
- Price
- NA $4.42
- AKTX $2.08
- Analyst Decision
- NA
- AKTX
- Analyst Count
- NA 0
- AKTX 0
- Target Price
- NA N/A
- AKTX N/A
- AVG Volume (30 Days)
- NA 162.9K
- AKTX 15.6K
- Earning Date
- NA 09-18-2024
- AKTX 11-26-2024
- Dividend Yield
- NA N/A
- AKTX N/A
- EPS Growth
- NA N/A
- AKTX N/A
- EPS
- NA N/A
- AKTX N/A
- Revenue
- NA $6,991,446.00
- AKTX N/A
- Revenue This Year
- NA N/A
- AKTX N/A
- Revenue Next Year
- NA N/A
- AKTX N/A
- P/E Ratio
- NA N/A
- AKTX N/A
- Revenue Growth
- NA N/A
- AKTX N/A
- 52 Week Low
- NA $2.75
- AKTX $1.08
- 52 Week High
- NA $47.50
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- NA 45.38
- AKTX 34.80
- Support Level
- NA $2.77
- AKTX $2.21
- Resistance Level
- NA $9.68
- AKTX $2.40
- Average True Range (ATR)
- NA 1.36
- AKTX 0.28
- MACD
- NA -0.02
- AKTX -0.00
- Stochastic Oscillator
- NA 23.88
- AKTX 20.15
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).